Increased prevalence of primary hyperparathyroidism in treated breast cancer

Journal of Endocrinological Investigation

Volumn 24, Issue 5, 2001, Pages 315-320

  Fierabracci, Paola ^a   Pinchera, A ^a   Miccoli, P ^a   Conte, P F ^a   Vignali, E ^a   Zaccagnini, M ^a   Marcocci, C ^a   Giani, C ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Breast cancer; Calcium; Hyperparathyroidism; Parathyroid adenoma; PTH

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCALCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; NEPHROLITHIASIS; OSTEOPOROSIS; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PREOPERATIVE EVALUATION; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PROSPECTIVE STUDY; THYROID CARCINOMA; THYROIDECTOMY;

EID: 0035000998     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343867     Document Type: Article

References (20)

1. Hypercalcemia of malignancy revisited
2. The hypercalcemia of cancer: Clinical implication and pathogenic mechanisms
3. Hypercalcemia in breast cancer
4. Hypercalcemia in breast cancer
5. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide
6. The pathogenesis of humoral hypercalcemia of malignancy
7. The physiology of parathyroid hormone-related protein
8. Parathyroid hormone-related protein: Elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer
9. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population
10. Role of assays for parathyroid-hormone-related-protein in investigation of hypercalcemia
11. Pancreatic islet cell carcinoma with hypercalcemia and hypergastrinemia
12. Pancreatic islet cell carcinoma with hypercalcemia: Complete remission after 5 years of hypercalcemia and chemotherapy
13. Distinguishing features of primary hyperparathyroidism in patients with breast cancer
14. NIH consensus development conference statement on primary hyperparathyroidism
15. Serum calcium survey for hyperparathyroidism: Results in 50,000 clinic patients
16. Primary hyperparathyroidism and breast cancer
17. Hyperparathyroidism following head and neck irradiation
18. Therapeutic radiation and hyperparathyroidism. A case control study in Rochester
19. Associated hyperparathyroidism and non medullary thyroid carcinoma: The etiologic role of radiation